A carregar...

Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells

Doxorubicin (Dox) clinical use is limited by dose-related cardiomyopathy, becoming more prevalent with increasing cumulative doses. Previously, we developed Dox-loaded lipid-core nanocapsules (Dox-LNC) and, in this study, we hypothesized that self-assembling and interfacial reactions could be used t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomaterials (Basel)
Main Authors: Antonow, Michelli B., Franco, Camila, Prado, Willian, Beckenkamp, Aline, Silveira, Gustavo P., Buffon, Andréia, Guterres, Sílvia S., Pohlmann, Adriana R.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791089/
https://ncbi.nlm.nih.gov/pubmed/29271920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nano8010002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!